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Abstract (250 words) 26 
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by a Th2-biased 27 
eosinophilic inflammation. Eosinophils have been shown to generate so-called extracellular 28 
eosinophilic traps (EETs) under similar pathological conditions. 29 
Objective: Our aim was to investigate a possible link between EET formation and the presence of 30 
Staphylococcus aureus, an organism frequently colonizing the upper airways, at the human mucosal 31 
site of the disease. 32 
Methods: Tissue slides were investigated for the presence of EETs and S. aureus, using 33 
immunofluorescent staining and PNA-fish assay respectively. An ex vivo human mucosal disease 34 
tissue model was used for artificial infection with S. aureus. Cell markers were analyzed using 35 
immunohistochemistry, luminex Multiplex assay, ELISA, PCR, immunobloting and linked to the 36 
presence of EETs.  37 
Results: About 8.8 ± 4.8 % of the infiltrating eosinophils exhibited EETs in patient’s nasal polyp 38 
tissues. The formation of EETs was associated with increased IL-5 (p < 0.05) and periostin (p < 0.05) 39 
tissue levels, and colonization with S. aureus (p < 0.05). Using an ex vivo human mucosal disease 40 
tissue model, EET formation was induced (4.2 ± 0.9 fold) upon exposure to S. aureus, but not to S. 41 
epidermidis. Eosinophils were shown to migrate (p < 0.01) towards S. aureus and entrap the bacteria 42 
both inside and outside the mucosal tissue. Blocking NAPDH oxidase activity, led to a complete 43 
inhibition (p < 0.05) of EET formation by S. aureus. 44 
Conclusion: Eosinophils are likely to be specifically recruited to and form EETs at sites of airway 45 
epithelial damage to protect the host from infections with S. aureus and possibly other 46 
microorganisms in CRSwNP. 47 
 48 
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Capsule Summary 51 
Eosinophils in nasal polyp tissue are likely to be recruited to sites of airway epithelial damage to 52 
protect the host against S. aureus infections by forming EETs. 53 
 54 
Key Messages  55 
- EETs are formed in nasal polyp tissue, mainly at subepithelial sites with epithelial barrier 56 
defects, and are associated with increased IL-5 tissue levels and S. aureus colonization.  57 
- EET formation is induced in nasal polyp tissue, upon exposure to S. aureus, but not to S. 58 
epidermidis. 59 
- Eosinophils migrate towards S. aureus and entrap the bacteria both inside and outside the 60 
mucosal tissue.  61 
- Reactive oxygen species are involved in this rapid process. 62 
 63 
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List of abbreviations 76 
AD : atopic dermatitis 77 
C5a : Complement factor 5a 78 
CRSwNP : Chronic rhinosinusitis with nasal polyps 79 
DAPI : 4',6-diamidino-2-phenylindole 80 
DNA : Deoxyribonucleic acid 81 
DPI : diphenyleneiodionium 82 
E. coli : Escherichia Coli 83 
EETs: extracellular eosinophilic traps 84 
IFN : interferon 85 
IL-5 : Interleukin 86 
IT : inferior turbinate 87 
lfTSLP : long form TSLP 88 
LPS : lipopolysachariden 89 
MBP : Major Basic Protein 90 
MGG : May-Grünwald-Giemsa staining 91 
ROS : reactive oxygen species 92 
S. aureus : Staphylococcus aureus 93 
S. epidermidis : Staphylococcus epidermidis 94 
sfTSLP : short form TSLP 95 
TCM : Tissue culture medium 96 
Th2 : T-helper 2 97 
TSLP : Thymic stromal lymphopoietin  98 
 99 
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1. Introduction 103 
Asthma, allergy, aspirin hypersensitivity and chronic rhinosinusitis with nasal polyps (CRSwNP) have 104 
all been characterized as Th2-biased eosinophilic inflammations and often represent comorbid 105 
diseases. 1-3 Nasal polyp tissue of Caucasian patients usually shows high levels of interleukin IL-5 and 106 
eosinophil-related chemokines.4 Together, these cytokines seem to orchestrate the chemotaxis, 107 
activation and survival of eosinophils.1,5,6 Tissue eosinophilia increases the likelihood of recurrent 108 
disease and comorbid asthma in CRSwNP patients, indicating that eosinophils play a central role in 109 
the pathology of CRSwNP.7 However, their role in airway disease and their contribution to the 110 
inflammation is not fully understood. 111 
Eosinophils have cytotoxic functions and are involved in both the innate and adaptive immune 112 
responses; they have been correlated with epithelial damage via the release of major basic protein 113 
(MBP).8 In addition, activated eosinophils can contribute to antibacterial defense by releasing 114 
mitochondrial DNA in association with granule proteins.9,10 In vitro, these so-called eosinophil 115 
extracellular traps (EETs) are able to bind and kill bacteria like S. aureus, S. epidermidis and E. coli.10,11  116 
Here we hypothesized that EETs are present and are activated in nasal polyp tissue by S. aureus. As a 117 
consequence, these findings could provide further insights and understanding of the underlying 118 
causative mechanisms that lead to eosinophilic nasal polyps. 119 
In vitro co-culture with eosinophils was sufficient to evoke EETs in the case of S. aureus, an additional 120 
stimulus with thymic stromal lymphopoietin (TSLP) was required for S. epidermidis to generate traps 121 
in vitro, suggesting differing responses of eosinophils according to the type of bacteria.10,11 Enzymatic 122 
digestion of extracellular DNA obviates the capacity of EETs for killing bacteria. This indicates that, 123 
despite the fact that DNA itself has no antibacterial effect, EETs need both intact DNA and granule 124 
proteins to orchestrate this function.12 The generation of EETs is considered to be an active process, 125 
not associated with cell death.10,12 In vitro, EET formation is stimulated by priming eosinophils with IL-126 
5, and interferon (IFN)-ɣ or adhesion molecules followed by activation with complement factor 5a 127 
(C5a), LPS, TSLP, and eotaxin.11,12 128 
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In addition to its association with eosinophilic inflammation, CRSwNP is also associated with a strong 129 
colonization by S. aureus.13 Interestingly, eosinophils were recently reported to generate EETs 130 
immediately after co-culture with S. aureus in vitro.11 This occurred without additional stimuli and as 131 
the result of both direct and indirect interactions. Under these circumstances, EETs were found to 132 
entrap and inhibit the growth of S. aureus.11 The observation that extracellular nucleases are found in 133 
various pathogenic bacteria including S. aureus, support the hypothesis of a pathophysiological 134 
relevance for extracellular DNA traps.14  135 
In recent years, EETs have been linked to various infectious and noninfectious diseases, including 136 
inflammatory skin and intestinal diseases. Unsurprisingly, EET formation is often observed in allergic 137 
diseases, such as bronchial asthma, contact dermatitis, atopic dermatitis (AD) and allergic drug 138 
reactions.9,15-17 In eosinophilic esophagitis and bullous pemphigoid, an increased presence of EETs is 139 
observed at sites of epithelial barrier defects.17 Therefore, EET formation could be an important 140 
mechanism for protecting against infections, but might simultaneously cause damage to the 141 
surrounding tissue, further compromising the epithelial barrier.12 As epithelial barrier defects are 142 
more and more recognized as a key factor in various diseases, it is likely that EET formation may 143 
contribute to the pathophysiology of chronic airway diseases. 144 
Altogether, these findings make eosinophils, EETs and their possible interactions with S. aureus an 145 
interesting field of study in chronic airway diseases. Data from our group have shown that CRSwNP is 146 
associated with eosinophilic infiltration, increased IL-5 and eotaxin 3, but also IL-33 and TSLP levels 147 
(unpublished data) and a consistent colonization with S. aureus. The presence of EETs was shown in 148 
endobronchial biopsies from asthma patients and in secretions of eosinophilic chronic rhinosinusitis 149 
patients.9,18 However, the dynamics of their activation and the factors regulating their release have 150 
not been clarified in human diseased mucosal tissue. We aimed to understand the relevant 151 
mechanism behind this activation in the context of clinical patient samples.  152 
 153 
 154 
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2. Materials and Methods 155 
2.1. Sample collection  156 
Nasal polyp tissue samples from 15 patients undergoing endoscopic sinus surgery for chronic 157 
rhinosinusitis with nasal polyps (CRSwNP) and inferior turbinates (IT) from healthy individuals (5 158 
patients undergoing septal surgery because of anatomical deviations) were collected. For the 159 
isolation of peripheral blood eosinophils, whole blood was collected from healthy volunteers. 160 
Written informed consent was obtained from all patients prior to enrollment in the study. Depending 161 
on the experiment, the tissues were either used immediately, snap frozen and/or embedded in 162 
paraffin. The study was approved by the local Ethics Committee (2015/0883) and the regulatory 163 
authorities of Belgium. None of the patients received intranasal, oral and/or intramuscular 164 
corticosteroids within the 4 weeks before surgery. For female subjects, pregnancy or lactation was 165 
excluded. Patient characteristics are summarized in Table 1.  166 
 167 
2.2. Isolation of peripheral eosinophils and migration assay. 168 
Blood eosinophils were puriﬁed using the granulocyte fraction after whole blood Ficoll-paque 169 
centrifugation from healthy donors using the CD16 depletion kit (Miltenyi Biotec) according to the 170 
manufacturer’s instructions. The purity of isolated eosinophils was determined as > 95% by May-171 
Grünwald-Giemsa (MGG) staining and light microscopy. 172 
For the migration assay, eosinophils were primed for 20 minutes with 50 ng/ml IL-5 (PeproTech) and 173 
then allowed to migrate through 5 µm pore size poly (vinylpyrrolidone)-free polycarbonate filters 174 
(VWR International) for 90 minutes at 37°C. The lower compartment contained RPMI 1640 with 5% 175 
Bovine Calf Serum (Life Technologies) and was considered as control tissue culture medium (TCM). 176 
TCM containing 10 ng/ml eotaxin (PeproTech) was used as a positive control.  Three days before the 177 
experiment primary epithelial cells, isolated from nasal polyp tissue as described previously 19, were 178 
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seeded (BEGM medium, Lonza) in the basolateral compartment. Before the migration assay, the 179 
medium was changed to TCM medium with or without 2x107 CFU S. aureus.  180 
After the migration assay, the membrane was subjected to MGG staining and its lower side was 181 
evaluated for the number of migrated eosinophils. The chemotactic index was calculated by dividing 182 
the number of cells migrating under the experimental condition by the number of cells migrating 183 
under TCM condition. 184 
 185 
2.3. Immunofluorescent staining 186 
The tissues were fixed in 4% paraformaldehyde and embedded in paraffin. After rehydration of the 187 
tissue slides (5 µm), they were subjected to different staining procedures. 188 
A. EET staining 189 
EETs were visualized in paraffin-embedded tissue slides (5 µm) by means of indirect 190 
immunofluorescence followed by counterstaining for DNA.  After blocking and incubation with the 191 
polyclonal anti-major basic protein (MBP) (Monosan) antibody (1:50), the slides were incubated with 192 
a fluorescein isothiocyanate-conjugated secondary antibody (1:400) (Life Technologies) and the DNA 193 
was stained by incubation with propidium iodide (1 µg/ml) (Sigma Aldrich). Subsequently the slides 194 
were analyzed with a confocal laser-scanning microscope (Leica MicroSystems). Since the EETs are 195 
difficult to detect in fixed tissues, staining was performed on three different tissues for each patient. 196 
For each patient and each piece of tissue, 5 fields were selected in the studied regions (stroma, 197 
subepithelial or at epithelial defects). In those fields, the amount of EETs was counted and 198 
normalized for the amount eosinophils. EETs were expressed as % of eosinophils generating EETs 199 
throughout the manuscript.  200 
B. Immunohistochemistry staining 201 
After blocking, the tissue slides were incubated with the primary antibody. Primary antibodies for 202 
MBP (Monosan) and Caspase-3 (1:200) (Cell Signaling Technology) were used for the staining of 203 
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eosinophils and apoptotic cells respectively. The immunohistochemistry stain was further performed 204 
using a REAL Detection System, Alkaline Phosphatase/RED kit (Dako) according to the manufacturer’s 205 
instructions. 206 
 207 
2.4. S. aureus staining 208 
Paraffin sections of nasal polyp tissue (for CRSwNP patients) or IT (for normal control patients) were 209 
rehydrated and incubated for 30 minutes with the S. aureus probe using PAN-fish kit (AdvanDx 210 
Company) at 55°C. After incubation, the unbound residual probe was removed by incubation with 211 
wash solution (AdvanDx Company) for 30 minutes at 55°C. After washing, the slides were 212 
counterstained with propidium iodide (1 µg/ml) (Sigma Aldrich) for 10 minutes at room temperature. 213 
Finally the slides were mounted and examined using a fluorescence microscope. Patients and 214 
controls were screened in triplicate for S. aureus and received a score as follows: ‘0’ no colonization; 215 
‘1’ planktonic colonization, not more than two bacteria in close proximity; ‘2’ planktonic colonization, 216 
more than two bacteria in close proximity; ‘3’ colonization with biofilm formation. 217 
To stain both S. aureus and EETs, the procedure was performed as described in 2.3. The slides were 218 
washed with PBS and subjected to the immunofluorescent staining as described above with following 219 
changes: a red fluorescent protein -conjugated secondary antibody (1:400) (Life Technologies) was 220 
used and the DNA was stained with 4',6-diamidino-2-phenylindole (DAPI) (Life Technologies). 221 
2.5. Staphylococcus exposure experiments 222 
S. aureus (kind gift of Prof. Dr. von Eiff, Münster, Germany) and S. epidermidis (ATCC 14990) were 223 
grown overnight in tris-buffered saline (TSB) and diluted in RPMI:DMEM (Dulbecco's Modified Eagle 224 
medium) (1:1) (Life Technologies) to 2x107 CFU/ml. Patient tissues were kept submerged in 2 ml of 225 
the bacteria solution or in tissue culture medium and maintained for 2 hours at 37°C. Tissues 226 
submerged in RPMI:DMEM medium, tissue control medium (TCM), was considered as control tissue. 227 
Subsequently, the tissues were placed on a stainless steel grid and incubated at air-liquid interface 228 
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for 30 minutes, 1 and 2 hours. For the inhibition experiment, the tissue cubes were pre-incubated 229 
(submerged) with 10 µM of the NADPH oxidase inhibitor diphenyleneiodionium chloride (DPI) in 230 
RPMI:DMEM for 1 hour at 37°C before proceeding as described above. After incubation, the tissues 231 
were immediately fixed in 4 % paraformaldehyde and/or snap frozen in liquid nitrogen.  232 
2.6. Reactive oxygen species measurements 233 
The tissues were immediately fixed in 4% paraformaldehyde and embedded in paraffin. Upon 234 
rehydration, tissue slides were incubated with 5 µM dihydroethidium (Sigma Aldrich) for 30 minutes. 235 
After washing steps with PBS, the slides were mounted with Vectashield anti-fade mounting medium 236 
(Vector Laboratories). The slides were evaluated under a confocal fluorescent microscope and 237 
pictures were taken while keeping the parameters (12 µs exposure time, 13% laser intensity) 238 
constant. For each experiment (n=3), 10 fields in the subeptihelial region (< 100 µm distance from 239 
epithelium) per condition were selected randomly, and assessed/measured by 2 (blinded) 240 
individuals. The fluorescent mean intensity was quantified and normalized for surface area by 241 
measuring the integrated fluorescent density using ImageJ analysis software. 242 
 243 
2.7. Immunoblot analysis for TSLP 244 
Protein lysates from patient tissues were made in RIPA buffer containing protease inhibitors (Sigma) 245 
as described previously.20 The concentration of protein in the lysates was determined using a protein 246 
assay (Bio-Rad) with bovine serum albumin as a protein standard. The lysates were mixed 1:1 tricine 247 
sample buffer (Bio-Rad) with 2% β-mercaptoethanol. Thirty micrograms of protein lysate was loaded 248 
on a tris-tricine 16.5% precast gel (Bio-rad). Proteins were transferred to nitrocellulose membrane 249 
and incubated in 5% bovine serum albumin overnight. Long form TSLP (lfTSLP) and short form TSLP 250 
(sfTSLP) protein were detected using anti-TSLP antibody (1:1000)(Abcam). The secondary antibody 251 
used was anti-rabbit Ig donkey whole Ab-HRP linked (1:6000) (NA934, GEAkta). Reactive bands were 252 
visualized using SuperSignal West Femto maximum sensitivity substrate (ThermoFisher Scientific).   253 
 254 
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2.8. Real-Time PCR 255 
Snap frozen tissue samples (± 30 mg) were disrupted and thawed directly into lysis solution (QIAGEN) 256 
followed by homogenization using a QIAshredder homogenizer (QIAGEN). Subsequently, RNA was 257 
isolated using the RNeasy Mini Kit (QIAGEN) following the manufacturer’s instructions. RNA quality 258 
was assessed with an Experion Automated Electrophoresis System (Bio-Rad Laboratories, Belgium) 259 
and cDNA was synthesized from 1 µg of RNA using the iScript Advanced cDNA Synthesis Kit for RT-260 
qPCR (Bio-Rad). Quantitative real-time PCR was used to quantify mRNA levels of TSLP. Amplification 261 
reactions were performed on a Light Cycler LC480 System (Roche) by using a specific PrimePCR Assay 262 
(Bio-Rad). qPCR reactions contain 5 ng cDNA (total RNA equivalent), 0.25 µl PrimePCR primermix 263 
(Bio-Rad), 2.5 µl SsoAdvanced Universal SYBR Green Supermix (Bio-Rad) in a final volume of 5 µl. PCR 264 
protocol consisted of 1 cycle at 95°C for 2 minutes followed by 44 cycles at 95°C for 5 seconds, at 265 
60°C  for 30 seconds and at 72°C  for 1 second, and a dissociation curve analysis from 60°C to 95°C. 266 
After a validation with geNorm (Biogazelle, Belgium), two reference genes, elongation factor 1 (EF-1) 267 
and succinate dehydrogenase complex flavoprotein subunit A (SDHA), were used to normalize for 268 
transcription and amplification variations among samples. Primer sequences are shown in Table S2. 269 
The normalized relative quantities (NRQs) were calculated with the qBase+ software (Biogazelle, 270 
Belgium) and the final gene expression results are expressed as the logarithm of NRQs per 5 ng 271 
cDNA.  272 
 273 
2.9. Cytokine measurements 274 
The frozen tissues were weighed, homogenized and centrifuged as described previously.20 The 275 
samples were then assayed for IL-5, TSLP and periostin using commercially available ELISA kits from 276 
R&D Systems (Minneapolis, Minnesota, USA) and for ECP and IgE using the UniCAP method (Thermo 277 
Fisher Scientific) with the appropriate dilution factor and according to kit instructions. The samples 278 
were measured following the instructions of the manufacturer, on a Bio-Plex 200 Array Reader (Bio-279 
Rad, Hercules, CA, USA). 280 
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2.10. Statistical analysis 281 
Statistical analysis was performed using the SPSS version 23 software program. For between-group 282 
comparisons (Fig. 3A-C, Fig. 5C, Fig. 7AB, Fig. S1 A-D, Fig. S3 A-B, Fig. S4 A-D) the Mann-Withney U 283 
test was used. For the comparison of related samples (comparison of EET formation related to tissue 284 
localization, Fig. 4 E, Fig. 6 A-C, H ), data were analyzed with a Friedman test, followed with Dunns 285 
post test. Linear correlation analysis (Fig. S3 C-D) was performed with a Spearman correlation test. 286 
Significances were expressed as *p<0.05,**p<0.01, ***p<0.001, p-values less than or equal to 0.05 287 
were considered as statistically significant. 288 
 289 
 290 
 291 
 292 
 293 
 294 
 295 
 296 
 297 
  298 
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3. Results 299 
Subepithelial eosinophils in nasal mucosa of patients with CRSwNP  300 
CRSwNP patients selected for the study (Table 1) had significantly elevated tissue levels of IgE, IL-5 301 
and ECP (Fig. S1 A-C) compared to the normal controls. Significant number of eosinophils (Fig. S1D 302 
and Fig. S1 E-F, p < 0.001), and to a much lesser extent neutrophils (Fig. S1D, p < 0.05) were elevated 303 
in the tissues of  the diseased population. 304 
No infiltration or alignment of eosinophils was observed in the IT control population (n=5, Table S1 305 
and Fig. 1A). In the tissue of the control population, eosinophils were rarely observed, even in the 306 
allergic individuals. An increased presence and alignment of eosinophils underneath both intact (Fig. 307 
1B) and barrier defective epithelium (Fig. 1D-E) was observed in all CRSwNP patients Table S1, n=15). 308 
In some patients however, the alignment was more pronounced than in others. Regions with 309 
completely denuded epithelium (Fig. 1E) were always associated with subepithelial infiltrates of 310 
eosinophils. In the latter case, the subepithelial region could range from large and diffuse depositions 311 
of MBP or free granules with very few to no intact eosinophils showing clear tissue damage (Fig. 1E), 312 
to infiltrations of large numbers of intact eosinophils, depending on the patient and the localization 313 
within the polyp. Regions with visually deviant epithelium (e.g. single cell layers, missing epithelial 314 
cells) were often associated with larger and denser zones of subepithelial eosinophils Fig. 1C).   315 
Increased presence of EETs in subepithelial regions 316 
Although there were substantial differences between patients, we observed EETs in all of the 15 317 
patients analyzed. Considering all patients, the mean fraction of EET-releasing eosinophils in the 318 
subepithelial region (selected as region < 100 µm distance from epithelium) was 8.8 ± 4.8 % of the 319 
infiltrating eosinophils, but ranged from < 2 % to 15 % of the eosinophils contributing to EET 320 
formation (Fig. 2A). The proportion of EET-releasing eosinophils was differently distributed 321 
throughout the polyp. Deep in the stroma, eosinophils were found mainly intact (Fig. 2B) (and 322 
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sometimes degranulated) and EET formation was very rare (0.2 ± 1.1% of the eosinophils); 323 
subepithelially (< 100 µm distance from epithelium) denser eosinophilic infiltrates (Fig. 2C) were 324 
located wherein eosinophils were found intact, or degranulating, releasing single EETs (Fig. 2D) 325 
and/or clusters of eosinophils releasing EETs (Fig. 2E). The long and thin EET structures often seemed 326 
to align underneath the epithelium, and sometimes even seemed to connect the EET releasing 327 
eosinophils with other cells including other eosinophils. In most of the specimens we observed more 328 
clusters of eosinophils releasing EETs than single EET releasing cells. No EET- releasing eosinophils 329 
were found in the control ITs. No correlation was found between the extent of EET formation and 330 
presence of atopy or asthma. 331 
Subepithelial regions with enhanced EET formation are not correlated with the presence of 332 
apoptotic epithelial cells. 333 
In the subepithelial region (< 100 µm distance from epithelium), the proportion of eosinophils 334 
generating EETs was in general higher than in the stroma. The subepithelial regions with visual 335 
deviant epithelium showed a significant increase of EETs (3.1 ± 1.9 fold, p < 0.01), compared to 336 
subepithelial regions with intact epithelium. These abnormal epithelial regions with increased 337 
subepithelial eosinophilic infiltrates (Fig. S2 A) were not characterized by apoptotic (epithelial) cells 338 
(Fig. S2 B), as indicated by an IHC stain for caspase-3. We also observed no abnormal nuclear 339 
morphology in infiltrating eosinophils, indicating that cell lysis did not occur under the conditions of 340 
EET formation (Fig. S2 B, inset B’). 341 
EET formation is associated with elevated IL-5 and periostin levels, and with S. aureus infection 342 
CRSwNP patients with higher numbers of infiltrating eosinophils had significantly higher (relative) 343 
amounts of EET formation (p < 0.05, Fig. S3 A). Patients with EETs were characterized by significantly 344 
higher IL-5 levels in the tissue (Fig. 3A).  Periostin levels were significantly increased in CRSwNP 345 
patients, compared to controls (p < 0.01, Fig. S3 B) and were positively correlated with IL-5 levels (p < 346 
0.01, R²=0.665, Fig. S3 C). In addition, patients with more EETs had significantly increased periostin 347 
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levels in the tissue (Fig. 3B). Interestingly, no correlation between EET formation and TSLP protein 348 
concentration (Fig. S3 D) was found in the tissue. 349 
Because of the well-known association between S. aureus colonization and IL-5, all patients (n=15) 350 
were evaluated and received a score (Table 2) for the S. aureus infection status as indicated in the 351 
Materials and Methods section. The group of CRSwNP patients with the highest percentages (10% < x 352 
< 20%, Fig. 3C) of eosinophils generating EETs, had a significant higher score for S. aureus 353 
colonization than the patients with the lowest (< 5%, Fig. 3C, p≤ 0.05) and intermediate EET levels (< 354 
10 %, Fig. 3C, p≤ 0.01). 355 
Based on findings described above, five patients with high EET formation and S. aureus colonization 356 
were selected and screened for co-localization of S. aureus and EETs in the tissue. In 3 of the 5 357 
patients, S. aureus was found entrapped in an EET in the tissue (Fig. 3D). Other EETs were often 358 
observed in the neighborhood of S. aureus bacteria. 359 
In vitro exposure of S. aureus, but not S. epidermidis, leads to increased EET formation in tissue 360 
fragments 361 
After  one hour exposure of CRSwNP tissue fragments to S. aureus in air-liquid culture, EET formation 362 
was markedly enhanced (3.5 ± 1.2 fold increase, Fig. 4B and Fig. 4E) with up to 60% of eosinophils 363 
(local effect) contributing to EETs as compared to the TCM control (Fig. 4A). The traps formed were 364 
connected with each other as well as with other cells. After 2 hours exposure in air-liquid culture, we 365 
noticed the increased presence of eosinophils releasing EETs at sites where S. aureus was observed 366 
(4.2 ± 0.9 fold increase, Fig. 4C and Fig. 4E). The EET formation was concentrated in the subepithelial 367 
regions (Fig. 4C) and, more specifically, at sites with epithelial defects and near S. aureus. These 368 
findings were in strong contrast to the results of similar exposure experiments with S. epidermidis 369 
(Fig. 4D) where no increased EET formation (Fig. 4E) could be observed at any time point.  370 
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Eosinophils migrate towards and entrap S. aureus in an ex vivo diseased human mucosal tissue 371 
model 372 
In the ex vivo human tissue model, after 2 hours air-liquid exposure, large numbers of eosinophils 373 
were concentrated (compared to the general distribution of eosinophils in the tissue) at the sites of 374 
epithelial defects, having sometimes even migrated out of the tissue. The eosinophils trapped S. 375 
aureus at sites of epithelial defects (Fig. 5A), but also at sites with an intact, but single cell-layered 376 
epithelium (Fig. 5B).  Active migration of eosinophils towards S. aureus was confirmed by an in vitro 377 
migration assay (Fig. 5C). In addition, the migration towards S. aureus was enhanced by the 378 
combined presence of S. aureus and epithelial cells and had a tendency to further increase further 379 
with longer co-incubation times (4 hours). 380 
Isolated cells from nasal secretions of CRSwNP patients were shown to be extremely reactive with 381 
massive EET formation upon ex vivo challenge with S. aureus for 15 minutes without the need for 382 
priming. The bacteria were found entrapped in the massive EET network (Fig. 5D). 383 
In vitro generation of EETs in response to S. aureus is associated with elevated production of 384 
reactive oxygen species 385 
Measurements of reactive oxygen species (ROS) in the tissue revealed a significant increase in ROS 386 
production after exposure to S. aureus. The production of ROS was significantly enhanced after 30 387 
minutes (Fig. 6A) and  one hour exposure to S. aureus as compared either to the TCM control or to a 388 
comparable exposure to S. epidermidis (Fig. 6B). After 2 hours, no further significant differences in 389 
ROS production between the different in vitro conditions were observed (Fig. 6C). The role of ROS 390 
and NADPH oxidase was confirmed by pretreatment of the tissue with DPI (Fig. 6D-G and Fig. 6H) 391 
which was able to block totally (Fig. 6G and Fig. 6H) the extensive EET formation caused by exposure 392 
to S. aureus (Fig. 6E).  393 
Periostin and TSLP levels were not significantly increased after in vitro exposure to S. aureus 394 
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Periostin (Fig. 7A) and TSLP levels (Fig. 7B) were not significantly elevated in tissue homogenates 395 
after exposure to S. aureus, as determined by ELISA. Immunoblot analysis (Fig. 7C) showed that the 396 
short form TSLP (sfTSLP) was undetectable, while the expression of long form TSLP (lfTSLP) was not 397 
significantly altered between the different conditions. At the mRNA level, lfTSLP was elevated after 2 398 
hours exposure to both S. aureus and S. epidermidis (Fig. 7D), although in the latter case the increase 399 
was not statistically significant. ELISA measurements of supernatant showed only detectable 400 
(secreted) TSLP levels after 2 hours exposure to S. aureus (data not shown), but in none of the earlier 401 
time points was TSLP detectable in the supernatants. 402 
 403 
4. Discussion 404 
The generation of EETs has been linked to various pathologies, including inflammatory skin and 405 
intestinal diseases. Unsurprisingly, EET formation was also observed in allergic diseases, such as 406 
bronchial asthma, contact dermatitis, atopic dermatitis (AD) and allergic drug reactions.9,15-17 Our aim 407 
was to investigate the presence of EETs in CRSwNP tissues. Due to the eosinophilic environment and 408 
the increased levels of IL-5, eotaxin and TSLP, we believed this was an ideal context for the 409 
generation of EETs. Our data have now shown that EETs are also formed in the nasal polyp tissues. 410 
An increased presence of eosinophils and EETs was observed at subepithelial sites, especially at sites 411 
with epithelial defects. These data are in line with similar observations described in eosinophilic 412 
esophagitis and bullous pemphigoid.21 Our research in patient samples showed that about 9% of the 413 
eosinophils present contribute to EET formation. It is very likely that EET formation in vivo is much 414 
more frequent as EETs are generated in a very short time frame, and possibly rapidly degraded.  415 
The relationship between S. aureus and elevated levels of IL-5 and CRSwNP has been recognized for 416 
years.5,13 The antibacterial properties of EETs and their formation as a response to S. aureus in vitro, 417 
made it interesting to study this relationship in the context of clinical tissue samples from CRSwNP 418 
patients. Our data have now shown that EET formation is associated with increased IL-5 levels, but 419 
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also with S. aureus colonization in patient’s tissues. In addition, we show for the first time direct 420 
proof of S. aureus entrapment by EETs in patient’s tissues. Furthermore, we were able to show the 421 
induction of EET formation after exposure to S. aureus, but not to S. epidermidis in tissues of CRSwNP 422 
patients. The presence of DNA traps in secretions of eosinophilic chronic rhinosinusitis patients and 423 
their role in increasing the viscosity of these secretions has already been reported.18 Our experiments 424 
now demonstrate that eosinophils migrate towards S. aureus and entrap the organism both inside 425 
and outside the human diseased mucosal tissue. Eosinophils from CRSwNP patient tissues showed a 426 
massive reactivity towards S. aureus exposure with extensive EET formation. This suggests that the 427 
reaction in the patient and at the diseased location could be far more extensive than currently is 428 
recognized from in vitro exposure experiments using peripheral eosinophils. In contrast to the 429 
situation in diseased tissue, in vitro exposure also needed prior priming for EET formation. These data 430 
also imply that a direct contact between the bacteria and the eosinophil is likely to initially trigger 431 
EET formation. This could also explain the increased EET formation at sites of epithelial defects. 432 
Our results imply that eosinophils are likely to be specifically recruited to and generate EETs at sites 433 
of epithelial damage, possibly to protect the host from infections. In nasal polyps, several defects in 434 
the mucosal defense have been shown, including increased levels of M2 macrophages, a decrease in 435 
β-defensin 2 and 3, defective epithelial tight junctions, a compromised expression of Toll-like 436 
receptor 9, etc.22-25 In this situation, eosinophil-mediated immune responses, like EET formation, 437 
might be crucial for maintaining the barrier function after inﬂammation-associated epithelial cell 438 
damage, protecting the host from an uncontrolled invasion of bacteria. 439 
This hypothesis is further supported by, (i) the increased presence and alignment of eosinophils at 440 
subepithelial sites, (ii) the observed migration and entrapment of S. aureus in the in vitro exposure 441 
model and (iii) the in vitro migration assay confirming an active migration of eosinophils.  As the 442 
cytotoxicity of eosinophilic granule proteins is well known, our observations could also point to a 443 
more prominent role of eosinophils in damaging or preventing the repair of the epithelial barrier in 444 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 19
CRSwNP.21,26,27 Whether the observed EETs are a causal effect of damage to the epithelial barrier, or 445 
(partly) the source of epithelial damage, will be the subject of future investigations.  446 
Recently the subepithelial deposition and association between periostin and eosinophilic 447 
inflammation was shown in CRSwNP.28 This made periostin an interesting candidate to investigate in 448 
association to EET formation.  Indeed, we found significant elevated periostin levels in patients with 449 
more EETs. Despite this fact, no increase in periostin was found after experimental exposure to S. 450 
aureus. This can possibly be attributed to the short time frame wherein we studied the trap 451 
formation. In addition, periostin could facilitate the infiltration of eosinophils in the tissue, as 452 
reported for allergic lungs and eosinophilic esophagitis.29 Therefore, periostin could be increased as a 453 
consequence of the Th2 context without being directly involved in EET formation. 454 
Interestingly, the induced generation of the EETs was observed within a narrow time frame (1 hour). 455 
With these observations, questions arise about the trigger of EETs release in the tissue after 456 
exposure. Our experiments have clearly shown that, upon stimulation with S. aureus, ROS levels are 457 
increased within the same time frame. Previously, it had been demonstrated that inhibition of 458 
NADPH oxidase activity, responsible for ROS production, also inhibited EET formation by eosinophils 459 
in vitro.10,11 Our data have shown that inhibition of NADPH oxidase was also able to block ROS 460 
production and EET formation in human mucosal tissue, implying an important role of NADPH 461 
oxidase activity in EET formation following S. aureus challenge in vivo.  462 
To our knowledge, a similar role for eosinophilic granule proteins has not been reported. We feel 463 
that solving this question is beyond the scope of our manuscript and would imply a separate EET-464 
based study. However, would like to thank the reviewer for highlighting this as we feel this could be a 465 
valuable hypothesis for our future research. 466 
 IL-5 and TSLP are both well-known triggers of EET formation in vitro.10,11,16 Therefore IL-5 and TSLP 467 
were investigated as potential triggers for EET formation in CRSwNP tissues. Unsurprisingly, 468 
increased IL-5 levels were indeed associated with more EETs. Interestingly however, TSLP levels were 469 
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not markedly enhanced in the tissue as determined by ELISA. This was in contrast to our expectations 470 
since TSLP is known to be elevated after epithelial damage, was correlated with EET release in active 471 
eosinophilic esophagitis and had been reported to directly trigger EET formation.11,21,31. Previously, 472 
EETs were described as capable of entrapping and killing S. aureus and S. epidermidis in vitro. In 473 
contrast to S. aureus, direct contact with S. epidermidis was not sufficient for EET release and was 474 
dependent on the addition of TSLP to execute this effect.11 This could explain why EETs were mainly 475 
concentrated at sites of epithelial defects (direct contact with S. aureus) and why S. epidermidis was 476 
unable to induce EET formation in the experimental human mucosal exposure experiments, as TSLP 477 
levels were not elevated in the time frame studied. PCR data however, showed an increase in TSLP 478 
production after two hours. Therefore, it is possible that at later time points, TSLP could still play a 479 
role in EET formation. 480 
Altogether these data imply that the tissue context, the nature of the trigger and the interplay 481 
between these two, play an important role in determining the intensity of EET formation. It is likely 482 
that the initiation of EET formation is triggered by direct contact between S. aureus and eosinophils 483 
and that, as a consequence of secondary signaling events, EET formation in later stadia is further 484 
supported by increased IL-5, TSLP or other triggers at later time points. 485 
In neutrophils it was shown that, besides ROS, also the granule proteins neutrophil elastase and 486 
myeloperoxidase had a regulatory role in the formation of NETs. 30 Eosinophilic granule proteins 487 
could possibly exert a similar function in EET formation but this is subject of future research. 488 
Although EET formation seems to have a beneficial role by targeting S. aureus, the targeting of 489 
eosinophils in eosinophils-associated diseases is highly effective. This paradox raises questions about 490 
cause and consequences in the pathophysiologic role of epithelial barrier defects, germs such as S. 491 
aureus, and the type-2 inflammatory reaction. 492 
In conclusion, we describe here for the first time the formation of EETs in nasal polyp tissue; their 493 
localization, dynamics and relationship with the presence of S. aureus, suggesting a role for EETs in 494 
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epithelial barrier defects. ROS could be identified as essential requirement for EET formation by 495 
eosinophils. These findings yield new insights into the possible role of EETs in human airways, and 496 
link S. aureus to eosinophilic airway disease such as CRSwNP and co-mordid asthma.  497 
 498 
 499 
 500 
 501 
 502 
 503 
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6. Figures 524 
  CRSwNP Controls 
Total cases  15 5 
Gender M/F 10/5 3/2 
Age Median (range) 35 (21-92) 33 (29-42) 
Ethnicity  Caucasian Caucasian 
Allergy -/+ 2/12 2/2 
 missing cases n=1 n=1 
Asthma -/+ 7/7 1/4 
 missing cases n=1 n=0 
Treatment asthma -/+ 4/3 2/2 
IgE Mean ± SD 1448.64 ± 1935.70 62.03 ± 77.95 
SAE-IgE Mean ± SD 6.85 ± 7.41 BDL 
 525 
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Table 1. Patient characterization.  Chronic rhinosinusitis with nasal polyps (CRSwNP), Male (M), 526 
Female (F), present (+), not present (-), below detection limit (BDL), standard deviation (SD), 527 
immunoglobulin E (IgE), S. aureus specific immunoglobulin E (SAE-IgE). Allergy was defined as 528 
‘present’ when the patient has a positive skin prick test for at least one of the allergens commonly 529 
tested in our region.  530 
 531 
 532 
 533 
 534 
 535 
 536 
 537 
 538 
 539 
 540 
 541 
 542 
 543 
 544 
 545 
 546 
 547 
 548 
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 549 
Fig. 1 Eosinophils in nasal mucosa tissue. (A-E) Immunohistochemical stain for MBP (red) in the 550 
subepithelial region of inferior turbinate from a control patient (A) and polyp tissue from different 551 
patients (B-E) showing the localization of eosinophils and different intensities of subepithelial 552 
localization. Nuclei (blue) are counterstained with hematoxylin. (Scale bar = 100 µm)  553 
 554 
Fig. 2 Eosinophils and their DNA traps in nasal polyp tissue. (A) Quantification of EETs in the 555 
subepithelial region of patients (NP 1-15) and control (IT 1-5) tissues, EETs were expressed as % of 556 
eosinophils generating EETs relative to the total amount of present eosinophils.  (B-E) 557 
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Immunofluorescent staining of MBP (green) and DNA (red). (B) Intact eosinophils in the stroma (scale 558 
bar = 25 µm), (C) increased subepithelial eosinophilic aggregation (scale bar = 50 µm), (D) a single 559 
eosinophil is shown generating an EET (indicated by an arrowhead) (scale bar = 5 µm) (E) a cluster of 560 
eosinophils generating EETs (indicated by arrowheads). (Scale bar = 10 µm).  561 
562 
Fig. 3 Relevant percentage of eosinophils forming EETs and IL-5, periostin and S. aureus 563 
colonization. Tissue levels of IL-5 and periostin were measured (CRSwNP patients, n=15) by means of 564 
ELISA. S. aureus colonization was assessed for all patients using a PNA-Fish technique. These data 565 
were studied for bacteria association with EETs. (A) IL-5 levels were elevated in patients where higher 566 
fractions of eosinophils generating EETs were observed.  (B) Periostin levels where increased where 567 
higher fractions of eosinophils generating EETs were detected. (C) In patients, increased EET 568 
formation significantly correlated with higher scores for S. aureus colonization. Data were analyzed 569 
by a Mann-Whitney U test, significances are expressed as *p<0.05,**p<0.01, ***p<0.001. (D) Co-570 
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localization of S. aureus and EETs.  Immunofluorescent staining for MBP (red) and DNA (blue) 571 
combined with a PNA-Fish stain for S. aureus (Green). (left picture scale bar = 25 µm, right picture 572 
scale bar = 50 µm) 573 
 574 
 575 
 576 
 577 
 578 
 579 
 580 
 581 
 582 
 583 
 584 
 585 
Fig. 4 EETs in nasal polyp tissue after in vitro exposure to S. aureus or S. epidermidis. 586 
Immunofluorescent stain for MBP (green) and DNA (red). (A) Intact eosinophils after 2 hours air-587 
liquid exposure to tissue culture medium (control) (Scale bar = 25 µm); (B) increased EET formation 588 
(arrowheads indicate some, but not all, of the EETs) after 1 hour air-liquid exposure to S. aureus 589 
(Scale bar = 25 µm); (C) increased subepithelial formation of EETs (dashed line) in the proximity of S. 590 
aureus (arrow) (scale bar = 25 µm); (D) mainly intact eosinophils after 2 hours air-liquid exposure to 591 
S. epidermidis. (Scale bar = 50 µm); (E) Increase of EET formation in the subepithelial region after 592 
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exposure to S. aureus (Sa) and S. epidermidis (Se) compared to tissue culture medium (TCM) in 593 
nasal polyp tissue (n=3). Data were analyzed with a Friedman test, followed with Dunns post test, 594 
significances are expressed as *p<0.05,**p<0.01, ***p<0.001 595 
596 
Fig. 5 Transepithelial migration and massive EET formation of eosinophils to entrap S. aureus. 597 
Immunofluorescent staining of MBP (red) and DNA (blue), combined with PNA-Fish stain for S. aureus 598 
(green) in tissue sections after 2 hours exposure to S. aureus. (A) Indicates the migration of 599 
eosinophils and EETs at sites of epithelial defects where direct contact with S. aureus is observed. 600 
(Scale bar = 25 µm) (B) Indicates transepithelial migration of a large fraction of eosinophils and the 601 
trapping of S. aureus in a large EET. (Scale bar = 25 µm) (C) In vitro migration assay of eosinophils in 602 
response to different stimuli: tissue culture medium (TCM), eotaxin, S. aureus (Sa), epithelial cells 603 
(ec), epithelial cells with S. aureus (ec+Sa), and epithelial cells with S. aureus after 4 hours of co-604 
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incubation (ec+Sa 4h). Data were analyzed with a Mann-Whitney U test, n=3, significances are 605 
expressed as *p<0.05,**p<0.01, ***p<0.001. (D) Eosinophils from a CRSwNP patient showing EET 606 
formation after challenge with S. aureus in vitro. (Scale bar = 25 µm) 607 
 608 
Fig. 6 Reactive oxygen species formation after exposure to S. aureus, and inhibition of EET 609 
formation by DPI. (A-C) Production of ROS in the tissues after 0.5, 1 and 2 hours in vitro exposure to 610 
S. aureus (Sa) or S. epidermidis (Se) (n=3). (D-G) Immunofluorescent stain for MBP (green) and DNA 611 
(red). (D) intact eosinophils after 1 hours air-liquid exposure to tissue culture medium (control); (E) 612 
increased EET formation after 1 hour air-liquid exposure to S. aureus; (F) intact eosinophils after 1 613 
hour DPI treatment and 1 h air liquid exposure to tissue culture medium (control); (G) mainly intact 614 
eosinophils after 1 hour DPI treatment and 1 hour air-liquid exposure to S. aureus; (scale bar = 100 615 
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µm) (H) Increase of EET formation after exposure to S. aureus and inhibition by DPI treatment in 616 
nasal polyp tissue (n=3). Data were analyzed with a Friedman test, followed with Dunns post test, 617 
significances are expressed as *p<0.05,**p<0.01, ***p<0.001 618 
 619 
620 
Fig. 7 Periostin and TSLP levels after in vitro exposure to S. aureus. (A) Periostin levels in tissue 621 
homogenates were not significantly elevated after exposure to S. aureus. Black line represents the 622 
control value (TCM) (n=4). (B) TSLP levels, determined by ELISA, in tissue homogenates were not 623 
significantly elevated after exposure to S. aureus (n=4). (C) Western blot analysis showing no 624 
difference in lfTSLP expression in tissue homogenates after exposure to either S. aureus.  or S. 625 
epidermidis. In addition the western blot indicates that sfTSLP was not detected. (D) PCR analysis in 626 
tissue homogenates indicates an increase in lfTSLP after 2 hours exposure to S. aureus (n=3).  627 
 628 
 629 
 630 
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 631 
 632 
7. Supplemental information 633 
Primer sequence 
SDHA-FW TGGGAACAAGAGGGCATCTG 
SDHA-Rev CCACCACTGCATCAAATTCATG 
EF1-FW CTGAACCATCCAGGCCAAAT 
EF1-Rev GCCGTGTGGCAATCCAAT 
TSLP short form FW CGTAAACTTTGCCGCCTATGA 
TSLP short term Rev TTCTTCATTGCCTGAGTAGCATTTAT 
long form TSLP - FW GGGCTGGTGTTAACTTACGACTTCA 
long form TSLP - Rev ACTCGGTACTTTTGGTCCCACTCA 
Table S1. PCR primer sequences 634 
 635 
Investigated feature  CRSwNP 
(n/N) 
Controls 
(n/N) 
Degranulated eosinophils < 1% eosinophils/not present 5/15 5/5 
 < 10 % eosinophils 6/15 0/5 
 < 20 % eosinophils 4/15 0/5 
S. aureus presence Not present 7/15 4/5 
 Planktonic < 2 spots 4/15 1/5 
 Planktonic > 2 spots no biofilm 1/15 0/5 
 Biofilm 3/15 0/5 
Table S2. Semi-quantitative evaluation of investigated parameters including degranulation and 636 
colonization of S. aureus. 637 
 638 
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639 
Fig. S1 Characterization of the study population. Tissue levels of IgE (A), IL-5 (B), and ECP (C) were 640 
measured in all patients (CRSwNP, n=15) and controls (CTR, n=5) by means of ELISA and were found 641 
to be elevated in the CRSwNP patients. Eosinophils and neutrophils (D) were counted in tissue of 642 
controls and CRSwNP patients. Tissue slides stained for major basic protein in controls (E) and 643 
CRSwNP (F) showing the general distribution of eosinophils throughout the tissue (Scale bar = 100 644 
µm). Data were analyzed using a Mann-Whitney U test, significances are expressed as 645 
*p<0.05,**p<0.01, ***p<0.001 646 
 647 
 648 
 649 
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 650 
Fig. S2 Subepithelial eosinophils and damaged epithelium. Immunohistochemistry was performed 651 
on subsequent tissue slides and the same region was selected for pictures A-B. The protein of interest 652 
is stained in red/purple, nuclei are stained with hematoxylin (blue). (A) An immunohistochemical stain 653 
for MBP (red) shows the localization of eosinophils in polyp tissue. (Scale bar = 200 µm); (B) An 654 
immunohistochemical stain for caspase-3 (red) demonstrates very few apoptotic cells in the tissue. 655 
Inset image (B’) shows no evidence for cell lysis. (B: Scale bar = 200 µm, B’: scale bar = 10 µm) 656 
 657 
 658 
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Fig. S3 (A) Relation between EET formation and number of eosinophils in the tissues. Data were 659 
analyzed using a Mann-Whitney U test, significances are expressed as *p<0.05,**p<0.01, ***p<0.001 660 
 (B) Periostin levels in CRSwNP patients and controls. Data were analyzed using a Mann-Whitney U 661 
test, significances are expressed as *p<0.05,**p<0.01, ***p<0.001 (C) Scatterplot of periostin and IL-662 
5 levels in CRSwNP patients with a significant correlation (p=0.013, R²=0.665), as determined by 663 
Spearman Correlation. (D) Scatterplot of TSLP and % of eosinophils forming EETs with no correlation 664 
as determined by Spearman Correlation. 665 
 666 
 667 
 668 
 669 
 670 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 34
Fig. S4 (A) Relation between IL-5 and percentage of degranulated eosinophils. (B) Relation between 671 
periostin and percentage of degranulated eosinophils. (C) Relation between number of eosinophils 672 
and percentage of degranulated eosinophils. (D) Relation between S. aureus colonization and 673 
percentage of degranulated eosinophils.  674 
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  CRSwNP Controls 
Total cases  15 5 
Gender M/F 10/5 3/2 
Age Median (range) 35 (21-92) 33 (29-42) 
Ethnicity  Caucasian Caucasian 
Allergy -/+ 2/12 2/2 
 missing cases n=1 n=1 
Asthma -/+ 7/7 1/4 
 missing cases n=1 n=0 
Treatment asthma -/+ 4/3 2/2 
IgE Mean ± SD 1448.64 ± 1935.70 62.03 ± 77.95 
SAE-IgE Mean ± SD 6.85 ± 7.41 BDL 
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Fig. S1 Characterization of the study population. Tissue levels of IgE (A), IL-5 (B), and ECP (C) were 
measured in all patients (CRSwNP, n=15) and controls (CTR, n=5) by means of ELISA and were found to 
be elevated in the CRSwNP patients. Eosinophils and neutrophils (D) were counted in tissue of controls 
and CRSwNP patients. Tissue slides stained for major basic protein in controls (E) and CRSwNP (F) 
showing the general distribution of eosinophils throughout the tissue (Scale bar = 100 µm). Data were 
analyzed using a Mann-Whitney U test, significances are expressed as *p<0.05,**p<0.01, ***p<0.001 
 
Fig. S2 Subepithelial eosinophils and damaged epithelium. Immunohistochemistry was performed on 
subsequent tissue slides and the same region was selected for pictures A-B. The protein of interest is 
stained in red/purple, nuclei are stained with hematoxylin (blue). (A) An immunohistochemical stain for 
MBP (red) shows the localization of eosinophils in polyp tissue. (Scale bar = 200 µm); (B) An 
immunohistochemical stain for caspase-3 (red) demonstrates very few apoptotic cells in the tissue. Inset 
image (B’) shows no evidence for cell lysis. (B: Scale bar = 200 µm, B’: scale bar = 10 µm) 
 
Fig. S3 (A) Relation between EET formation and number of eosinophils in the tissues. Data were 
analyzed using a Mann-Whitney U test, significances are expressed as *p<0.05,**p<0.01, ***p<0.001 
 (B) Periostin levels in CRSwNP patients and controls. Data were analyzed using a Mann-Whitney U test, 
significances are expressed as *p<0.05,**p<0.01, ***p<0.001 (C) Scatterplot of periostin and IL-5 levels 
in CRSwNP patients with a significant correlation (p=0.013, R²=0.665), as determined by Spearman 
Correlation. (D) Scatterplot of TSLP and % of eosinophils forming EETs with no correlation as determined 
by Spearman Correlation. 
 
Fig. S4 (A) Relation between IL-5 and percentage of degranulated eosinophils. (B) Relation between 
periostin and percentage of degranulated eosinophils. (C) Relation between number of eosinophils and 
percentage of degranulated eosinophils. (D) Relation between S. aureus colonization and percentage of 
degranulated eosinophils. 
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Primer sequence 
SDHA-FW TGGGAACAAGAGGGCATCTG 
SDHA-Rev CCACCACTGCATCAAATTCATG 
EF1-FW CTGAACCATCCAGGCCAAAT 
EF1-Rev GCCGTGTGGCAATCCAAT 
TSLP short form FW CGTAAACTTTGCCGCCTATGA 
TSLP short term Rev TTCTTCATTGCCTGAGTAGCATTTAT 
long form TSLP - FW GGGCTGGTGTTAACTTACGACTTCA 
long form TSLP - Rev ACTCGGTACTTTTGGTCCCACTCA 
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Investigated feature  CRSwNP 
(n/N) 
Controls 
(n/N) 
Degranulated eosinophils < 1% eosinophils/not present 5/15 5/5 
 < 10 % eosinophils 6/15 0/5 
 < 20 % eosinophils 4/15 0/5 
S. aureus presence Not present 7/15 4/5 
 Planktonic < 2 spots 4/15 1/5 
 Planktonic > 2 spots no biofilm 1/15 0/5 
 Biofilm 3/15 0/5 
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